Literature DB >> 47263

Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors.

L Svanberg, B Astedt.   

Abstract

Ascitic fluid samples from 19 patients with ovarian carcinoma, 3 with a benign ovarian tumor, and 5 with cirrhosis of the liver were examined for their content of coagulation factors and components of the fibrinolytic system. The concentration of trypsin inhibitors in the ascitic fluid was significantly higher in the presence of carcinoma. Large amounts of FDP were found in the ascitic fluid in all patients with malignant tumors, but not in the other two groups. Determination of FDP may therefore make it possible to differentiate between malignant and nonmalignant ascitic fluid.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 47263     DOI： 10.1002/1097-0142(197505)35:5<1382::aid-cncr2820350522>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  10 in total

1.  Proteases and antiproteases related to the coagulation system in plasma and ascites--an approach to differentiate between malignant and cirrhotic ascites.

Authors:  J Schölmerich; U Zimmermann; E Köttgen; B A Volk; S Ehlers; W Gerok
Journal:  Klin Wochenschr       Date:  1987-07-15

2.  Coagulation and fibrinolytic activity of cerebrospinal fluid.

Authors:  M Anderson; K B Matthews; J Stuart
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

Review 3.  Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy.

Authors:  D M Scott-Coombes; S A Whawell; M N Vipond; L Crnojevic; J N Thompson
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

4.  Isolation of alpha 1-protease inhibitor from human normal and malignant ovarian tissue.

Authors:  A Bagdasarian; J Wheeler; G J Stewart; S S Ahmed; R W Colman
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

5.  [Study on the genesis of diffuse intravascular coagulation after implantation of a peritoneal-jugular le veen shunt (author's transl)].

Authors:  H Murr; J Grunst; J Eisenburg; E Hiller; V Zumtobel
Journal:  Klin Wochenschr       Date:  1980-01-15

6.  Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease.

Authors:  Z Gilead; R Zahavi; A Hatzubai; G Brufman; S Biran; D Sulitzeanu
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

7.  Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens.

Authors:  V Dolo; E Adobati; S Canevari; M A Picone; M L Vittorelli
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

8.  Intraperitoneal coagulation in chronic liver disease ascites.

Authors:  J Hoefs; T Barnes; P Halle
Journal:  Dig Dis Sci       Date:  1981-06       Impact factor: 3.199

9.  A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.

Authors:  A P Wilson; H Fox; I V Scott; H Lee; M Dent; P R Golding
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  Characterization of a 54 kDa, alpha 1-antitrypsin-like protein isolated from ascitic fluid of an endometrial cancer patient.

Authors:  N Tanaka; S Sekiya; H Takamizawa; N Kato; Y Moriyama; S Fujimura
Journal:  Jpn J Cancer Res       Date:  1991-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.